RecruitingNCT05981950

Real-world of AI in Diagnosing Retinal Diseases

Real-world Application of Using Artificial Intelligence in Diagnosing Retinal Diseases


Sponsor

Beijing Tongren Hospital

Enrollment

100,000 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study is to apply an artificial intelligence algorithm to diagnose multi-retinal diseases in real-world settings. The effectiveness and accuracy of this algorithm are evaluated by sensitivity, specificity, positive predictive value, negative predictive value, and area under curve.


Eligibility

Min Age: 1 YearMax Age: 100 Years

Inclusion Criteria2

  • fundus photography around 45° field which covers optic disc and macula
  • complete identification information

Exclusion Criteria1

  • insufficient information for diagnosis

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTartificial intelligence algorithm

Retinal diseases diagnosed by artificial intelligence algorithm


Locations(1)

Wen-Bin Wei

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05981950


Related Trials